Advantages and pitfalls of combining intravenous antithrombin with nebulized heparin and tissue plasminogen activator in acute respiratory distress syndrome

BACKGROUND: Pulmonary coagulopathy has become an important therapeutic target in acute respiratory distress syndrome (ARDS). We hypothesized that combining intravenous recombinant human antithrombin (rhAT), nebulized heparin and nebulized tissue plasminogen activator (TPA) more effectively improves...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Trauma Acute Care Surg
Main Authors: Rehberg, Sebastian, Yamamoto, Yusuke, Sousse, Linda E., Jonkam, Collette, Cox, Robert A., Prough, Donald S., Enkhbaatar, Perenlei
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485116/
https://ncbi.nlm.nih.gov/pubmed/24368367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TA.0b013e3182ab0785
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados